PAGP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
BUY now (impatient-entry friendly): PAGP is in a clear uptrend (bullish MA stack) and is pulling back slightly pre-market toward nearby support (S1 ~20.12). Options positioning is skewed bullish (low OI put/call) with elevated activity, suggesting dip-buying interest. While RSI is stretched/overbought and a fresh BofA downgrade caps near-term enthusiasm, the trend + supportive options sentiment make it a reasonable buy at/near current pre-market levels for a near-term move back toward ~21.00–21.28.
Trend is bullish: SMA_5 > SMA_20 > SMA_200 indicates a strong upward structure. MACD histogram is positive (0.0341) but contracting, implying bullish momentum is slowing (possible consolidation/pullback rather than trend reversal). RSI_6 ~79.97 is elevated/overbought, increasing the odds of a short pause or dip. Key levels: Pivot 20.564 (price below pivot pre-market is mildly bearish intraday), Support S1 20.121 then S2 19.847; Resistance R1 21.007 then R2 21.281. With pre-market ~20.34, the setup looks like a buy-the-dip within an uptrend, with first upside objective a reclaim of the pivot then R1.
Technical uptrend intact (bullish MA stack) with price pulling back toward support, offering a practical entry without waiting for a perfect setup.
Options market skew is bullish (very low OI put/call) and volume is elevated, implying constructive sentiment.
Financial mix improving on profitability: 2025/Q3 net income +151.52% YoY and EPS +111.76% YoY; gross margin +18.95% YoY.
Potential catalyst: next earnings (QDEC
on 2026-02-09 pre-market; if results confirm margin/profit durability, the trend can re-accelerate.
Quant pattern outlook provided: modeled odds suggest +0.79% next day, +3.54% next week, +7.41% next month (directionally supportive).
RSI is overbought (~
and MACD is positively contracting, raising near-term consolidation/pullback risk.
Recent analyst headwind: BofA downgrade to Underperform with a $19 target (below current), which can pressure sentiment and cap upside.
Revenue trend is negative (2025/Q3 revenue -7.05% YoY), so part of the EPS improvement may be mix/margins rather than top-line growth.
No supportive newsflow in the last week (no fresh positive catalysts in headlines).
Macro tape is slightly risk-off pre-market (S&P 500 -0.43%), which can dampen early session momentum.
Latest quarter: 2025/Q3. Revenue declined to $11.578B (-7.05% YoY), but profitability improved sharply: net income rose to $83M (+151.52% YoY) and EPS increased to $0.36 (+111.76% YoY). Gross margin improved to 6.59 (+18.95% YoY). Overall: top-line softness, but clear margin/profit expansion—constructive for a midstream-style cashflow story if it persists into the next earnings (QDEC 2025 on 2026-02-09 pre-market).
Recent trend is mixed/leaning cautious near-term: (1) 2026-01-28 BofA downgraded to Underperform from Neutral, PT $19 (bearish, below market). (2) 2026-01-23 Mizuho reiterated Outperform and raised PT to $23 (bullish, cites shift toward a pure-crude portfolio and strengthened platform). (3) 2025-11-25 Morgan Stanley maintained Equal Weight and raised PT to $22. Wall Street pros: portfolio shift/stronger crude platform and contracted-cashflow appeal. Cons: softer Permian crude backdrop and at least one major firm (BofA) sees downside to $19. Other flows/context: Hedge funds neutral; insiders neutral; no recent Congress trading data available.
Intellectia Proprietary Trading Signals
